Related Experiment Video
Updated: Feb 7, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
[mTOR inhibitors in kidney transplantation]
Barbara Bonino1, Ernesto Paoletti1, Luigina Marsano1
1Clinica Nefrologica, Dialisi, Trapianto, Università di Genova e Ospedale Policlinico San Martino, Genova.
Abstract:
A changing paradigm of treatment of kidney transplant recipients is a new, wider approach to immunosuppression, which should take into account both antiviral and anticancer effects, in addition to cardiovascular protection. Recent observations suggest that the early introduction of mammalian target of rapamycin inhibitors (mTORi) in association with low dose CNI may offer many of these effects. The present manuscript summarizes benefits and contraindications of combinations with mTORi in kidney transplant immunosuppressive strategies.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Kidney Structure
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

